Title of article :
Polyomavirus Associated Nephropathy: Frequency and Graft Survival Analysis in Northeast of Iran
Author/Authors :
Taraz Jamshidi ، Shirin Kidney Transplantation Complications Research Center - Mashhad University of Medical Sciences , Sajjadian ، Khadijeh Student Research Committee - Mashhad University of Medical Sciences , Emadzadeh ، Maryam Clinical Research Unit - Mashhad University of Medical Sciences , Saber Afsharian ، Malihe Department of Pathology - Faculty of medicine - Islamic Azad university, Mashhad Branch , Kalantari ، Mahmoud Reza Kidney Transplantation Complications Research Center - Mashhad University of Medical Sciences , Alenabi ، Anita Cancer Molecular Pathology Research Center - Mashhad University of Medical Sciences , Zeraati ، Abbas Ali Kidney Transplantation Complications Research Center - Mashhad University of Medical Sciences , Emadzadeh ، Ali Kidney Transplantation Complications Research Center - Mashhad University of Medical Sciences
Abstract :
Background Objective: Polyomavirus-associated nephropathy (PVAN), mainly caused by the BK virus, is one of the most important infectious complications of kidney transplantation. The leading histopathologic characteristics of PVAN is viral cytopathic effects, such as nucleomegaly with smudged or clumped chromatin and intranuclear ground-glass inclusion, mostly in tubular epithelial cells. Moreover, tubular necrosis, tubulitis, interstitial inflammation, atrophy, and fibrosis have been noted. Positive immunohistochemistry (IHC) staining for SV-40 highlights the infected epithelial cells of renal tubules. Methods: A total of 85 core needle biopsies of transplanted kidneys were evaluated histologically and were stained for SV-40 using the IHC method. In addition, a follow-up of graft failure was performed. Results: Our findings revealed that the frequency of polyomavirus infection in kidney transplant patients in the Northeast of Iran is 4.7%. There was no significant correlation between PVAN and graft rejection. Although a higher rate of graft loss was observed in PVAN patients, in comparison with non-PVAN patients (25% vs. 14.8%), the difference was not statistically significant. Moreover, patients with immunohistochemically confirmed PVAN and those with histopathologic features of viral-like cytopathic effects had significantly lower graft survival in the follow-up period (42.5 vs. 196.8 months and 109.4 vs. 205.7 months, respectively). Conclusion: The frequency of polyomavirus infection in kidney transplant patients in the Northeast of Iran is 4.7%. There was no significant correlation between PVAN and graft rejection. Furthermore, we observed that polyomavirus infection accelerates the course of graft loss.
Keywords :
Frequency , Graft survival analysis , Polyomavirus , associated nephropathy
Journal title :
Iranian Journal of Pathology (IJP)
Journal title :
Iranian Journal of Pathology (IJP)